Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vaxfab Enterprises has circulated its 42nd Annual Report and AGM notice for FY2024-25. The AGM is scheduled for Tuesday, 30th September 2025 at 12:00 PM at the company's registered office in Ahmedabad. Key items to be tabled at the AGM include: (1) adoption of audited FY25 financial statements, (2) reappointment of Mr. Nishant Subhashchandra Gandhi as Director (retiring by rotation), (3) ratification of M/s. A. Shubhangi & Associates as Secretarial Auditors for a five-year term (FY2025-26 to FY2029-30), (4) a proposal to increase authorised share capital from Rs. 9.30 crore to Rs. 35 crore by creating an additional 2.57 crore equity shares, and (5) a preferential issue of up to 2,54,94,763 fully convertible warrants to non-promoter allottees at Rs. 21.02 per warrant, aggregating to approximately Rs. 53.59 crore. Several new directors and key managerial personnel (CFO, Company Secretary) have been appointed during the year.
The proposed capital expansion is material: if fully converted, the warrant issue alone could raise ~Rs. 53.59 crore but would meaningfully dilute existing shareholders, while the authorised capital hike signals further fundraising plans ahead. Shareholders should review the rationale and likely use of proceeds, as preferential allotments to non-promoters and potential dilution are key near-term considerations for the stock.